Drugs / Unrelated cord blood
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03913312 | Sep 2018 → Dec 2019 | acute myeloid leukemia | Ruijin Hospital | Unknown | No outcome recorded |
| Phase 1/2 | NCT02127892 | Jan 2007 → Aug 2016 | severe combined immunodeficiency | Neena Kapoor, M.D. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Unrelated cord blood | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03913312 ↗ |